Literature DB >> 18928577

Present and future fertility preservation strategies for female cancer patients.

Elena S Georgescu1, Jeffrey M Goldberg, Stefan S du Plessis, Ashok Agarwal.   

Abstract

UNLABELLED: As survival rates with cancer treatment are steadily increasing, many women are now facing sterility due to treatment induced ovarian failure. This review will attempt to summarize the options for trying to preserve fertility in these patients. The optimal approach depends on the type of cancer, the type of treatment (e.g., radiation and/or chemotherapy), time available till onset of treatment, patient's age, and whether the patient has a partner. Ovarian transposition remains the standard of care for women undergoing pelvic radiation, although it has been suggested that it may be combined with ovarian tissue cryopreservation. For patients about to receive chemotherapy or whole body radiation, in vitro fertilization (IVF) with embryo cryopreservation is a well established treatment with a good success rate. However, it requires delaying cancer treatment for 2 to 4 weeks and a partner or willingness to use donor sperm. When these criteria cannot be met, more experimental options include oocyte cryopreservation for later IVF and ovarian tissue cryopreservation. The tissue may be autotransplanted back to the pelvis, when the patient is in remission, to attempt spontaneous conception or subcutaneously for easy access of follicle aspiration for IVF. Alternatively, it may be xenografted to immunocompromised mice to induce follicle maturation in preparation for retrieval for IVF. Emerging treatment options for fertility preservation include medication to prevent chemotherapy-induced oocyte damage and oocyte construction from somatic cell nuclei. IVF with donor oocyte remains an established option with a very high success rate for those who fail to conceive with the above measures or who elect not to avail themselves to experimental procedures. TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians. LEARNING
OBJECTIVES: After completion of this article, the reader should be able to demonstrate knowledge about fertility preservation when counseling appropriate female cancer patients, recall current clinical strategies to assist women cancer patients to try to maintain their fertility if they wish, and appraise future strategies as they develop.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18928577     DOI: 10.1097/OGX.0b013e318186aaea

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  8 in total

Review 1.  Prevention of ovarian damage and infertility in young female cancer patients awaiting chemotherapy--clinical approach and unsolved issues.

Authors:  Katharina Hancke; Vladimir Isachenko; Evgenia Isachenko; Jürgen M Weiss
Journal:  Support Care Cancer       Date:  2011-09-23       Impact factor: 3.603

Review 2.  A changing perspective: improving access to fertility preservation.

Authors:  Joseph M Letourneau; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen
Journal:  Nat Rev Clin Oncol       Date:  2010-08-24       Impact factor: 66.675

Review 3.  Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.

Authors:  Erin F Wolff; Marybeth Hughes; Maria J Merino; James C Reynolds; Jeremy L Davis; Craig S Cochran; Francesco S Celi
Journal:  Thyroid       Date:  2010-09       Impact factor: 6.568

4.  Oncofertility in Canada: cryopreservation and alternative options for future parenthood.

Authors:  R Ronn; H E G Holzer
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

5.  Effect of Human Ovarian Tissue Vitrification/Warming on the Expression of Genes Related to Folliculogenesis.

Authors:  Zahra Shams Mofarahe; Marefat Ghaffari Novin; Mina Jafarabadi; Mojdeh Salehnia; Mohsen Noroozian; Nassim Ghorbanmehr
Journal:  Iran Biomed J       Date:  2015-07-22

6.  Effect of Satureja khuzestanica essential oil against fertility disorders induced by busulfan in female mice.

Authors:  Abbas Ahmadi; Saleh Bamohabat Chafjiri; Rajab Ali Sadrkhanlou
Journal:  Vet Res Forum       Date:  2017-12-15       Impact factor: 1.054

7.  Samul-tang ameliorates oocyte damage due to cyclophosphamide-induced chronic ovarian dysfunction in mice.

Authors:  Jihyun Kim; Sooseong You
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

8.  Laparoscopic Ovarian Transposition and Ovariopexy for Fertility Preservation in Patients Treated with Pelvic Radiotherapy with or without Chemotherapy.

Authors:  L Turkgeldi; A Cutner; E Turkgeldi; A Al Chami; A Cassoni; N Macdonald; T Mould; A Nichol; A Olaitan; E Saridogan
Journal:  Facts Views Vis Obgyn       Date:  2019-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.